| |
PEPLIN LIMITED Company Summary |
|
| Discovery, development and commercialisation of prescription human therapeutic products for the treatment of cancer and other diseases which have limited therapeutic options. |
|
|
|
 |
Fax |
07 3250 1299 |
 |
|
Principal Sector |
Health & Pharm |
|
|
Principal Industry |
Biotechnology |
|
|
Listed |
2000/09/22 |
|
|
Homepage |
www.peplin.com |
|
| |
|
|
|
| Stock Exchange | Stock Code |  ASX:PEP | PEP | | | | | | | |
|
| |
NEWS |
 |
|
|
